Replies to post #158923 on Avid Bioservices Inc (CDMO)

[microbe_man]

OK, then why would they have stated the following in the abstract??

Using multiple tumor models in mice, we demonstrate PS targeting antibodies enhance the anti-tumor activity of multiple forms of therapy including anti-CTLA-4 and anti-PD-1 checkpoint inhibitor antibodies.